A Multiple Ascending Dose Study of Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers
Status:
Completed
Trial end date:
2019-10-10
Target enrollment:
Participant gender:
Summary
This multiple ascending dose study assesses the safety, tolerability and pharmacokinetics of
NP10679 when delivered intravenously in escalating dose levels in comparison to placebo.
Phase:
Phase 1
Details
Lead Sponsor:
Neurop Inc.
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS) Pharmaron